Utah Medical Products (UTMD) EPS (Basic) (2010 - 2026)

Utah Medical Products' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.82 for Q1 2026.

• On a quarterly basis, EPS (Basic) fell 11.01% year-over-year to $0.82 in Q1 2026; TTM through Mar 2026 was $3.21, a 2.21% decrease from a year earlier, with the FY2025 full-year figure at $3.29, down 17.63% from the prior year.
• EPS (Basic) rose to $0.82 in Q1 2026 per UTMD's latest filing, from $0.6 in the prior quarter.
• Across five years, EPS (Basic) topped out at $2.27 in Q4 2022 and bottomed at -$0.97 in Q4 2023.
• The 5-year median for EPS (Basic) is $0.98 (2024), against an average of $0.91.
• Across the five-year window, EPS (Basic) jumped 205.1% in 2022 and tumbled 142.82% in 2023, its largest moves.
• Year by year, EPS (Basic) stood at $2.27 in 2022, then tumbled by 142.82% to -$0.97 in 2023, then soared by 124.1% to $0.23 in 2024, then surged by 157.37% to $0.6 in 2025, then surged by 35.71% to $0.82 in 2026.
• Per Business Quant, the three latest UTMD EPS (Basic) figures stand at $0.82 (Q1 2026), $0.6 (Q4 2025), and $0.82 (Q3 2025).